SLB Limited vs Halliburton Company — Stock Comparison
Q·Score Breakdown
7
Buy
Overall
6.8
Hold
Quality
Health
Growth
Valuation
Sentiment
SLB
Clean balance sheet with low leverage (0.4× debt-to-equity).
⚠ earnings contracting 14% year-over-year.
HAL
Healthy balance sheet and financial position.
Analyst Consensus
BUY
Target $59.79 (+6.9%)
28 analysts
BUY
Target $41.64 (-0.1%)
25 analysts
Fundamentals
SLB
HAL
24.6×
Trailing P/E
23.0×
16.8×
Forward P/E
14.6×
9.3%
Profit Margin
6.9%
17.8%
Gross Margin
15.3%
14.1%
ROE
14.6%
2.7%
Revenue Growth
-0.3%
-13.8%
Earnings Growth
133.5%
0.69
Beta
0.69
—
Price / Book
—
$83.6B
Market Cap
$34.8B
$32 – $57
52-Week Range
$19 – $42
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.